You are here

  • Home
  • Online First
  • Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial

Authors

  1. Correspondence to Dr Aurelien Amiot; aurelienamiot{at}gmail.com
View Full Text

Citation

Amiot A, Seksik P, Meyer A, et al
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
Gut Published Online First: 25 November 2024. doi: 10.1136/gutjnl-2024-333281

Publication history

  • Received July 4, 2024
  • Accepted November 2, 2024
  • First published November 25, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.